Key Takeaways
1. Movetru has secured $1.9 million in pre-seed funding to innovate sports medicine through real-time biomechanical insights and proactive injury prevention.
2. The startup combines a wearable device with an AI-driven app, providing instant movement feedback and is currently used by teams like the Belfast Giants.
3. The funding round was led by Two Magnolias, with contributions from various investors, including experts in biomechanics and sports medicine.
4. Movetru aims to democratize biomechanical analysis, making it accessible to amateur athletes and community programs, particularly addressing the needs of female athletes.
5. The company’s focus on early diagnosis and injury prevention aligns with a growing trend in sports science towards proactive rather than reactive treatment methods.
Movetru, a startup based in Northern Ireland, has successfully secured $1.9 million USD (roughly €1.4 million) in pre-seed funding. The company’s mission is to revolutionize sports medicine by prioritizing real-time biomechanical insights and proactive injury prevention instead of just treatment.
Innovative Wearables for Athletes
Founded by Naomi McGregor, Movetru offers a unique combination of a wearable device and an AI-driven mobile app that provides instant feedback on movement. This system is currently utilized by sports teams, including the Belfast Giants, to enhance their performance and safety.
The funding round was spearheaded by the London-based investor Two Magnolias, with contributions from IAG Capital, HBAN, Angel Academe, AwakenAngels, and several angel investors who have expertise in biomechanics, sports, and medical technology. Key supporters like Professor Mark Batt, who specializes in sports and exercise medicine, and Jeff Mostyn, the former chairman of AFC Bournemouth, are noteworthy backers in this venture, as reported by Tech in Asia.
A Shift Towards Prevention
Movetru’s products illustrate a broader trend in contemporary sports science, which is evolving from reactive treatment methods post-injury to a preventative strategy. This shift has been gradual, starting from frameworks like Van Mechelen’s 1992 Sequence of Prevention, which now serves as a groundwork for technology-driven solutions. Movetru’s AI system enhances this progression by providing accessible movement diagnostics to athletes, coaches, and physiotherapists, eliminating the need for costly motion capture labs or specialized clinics.
This recent funding success showcases the growing inclusivity in sports technology. Previously, biomechanical analysis tools were mainly available in elite settings. Movetru’s mobile platform democratizes this technology for amateur athletes, schools, and community programs. This inclusivity is especially crucial for female athletes, who often face higher injury rates, such as ACL tears, and are underrepresented in sports science research. Movetru prioritizes this area of concern.
Importance of Early Diagnosis
The significance of early detection is resonating with tech-savvy audiences as well. A Reddit user remarked in a discussion about sports injury prevention, “Identifying those movement patterns early could greatly impact injury prevention.” This is exactly what Movetru strives to accomplish through its AI-enabled wearables.
In February 2025, the sports technology sector garnered $2.5 billion following a record €3.9 billion in January, according to Tech.eu, which also highlights Movetru’s €1.4 million Pre-Seed round. The company’s evidence-based development, which includes initial trials with 100 participants, places it in a growing field where investors and practitioners are increasingly calling for scientific rigor and innovation.
With solid initial support, reputable investors backing them, and a product already in use by significant sports organizations, Movetru is now looking to expand its operations and increase access to its movement tracking platform.
Source:
Link














